BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17846300)

  • 1. Pediatric heart transplantation in human leukocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population.
    Pollock-BarZiv SM; den Hollander N; Ngan BY; Kantor P; McCrindle B; West LJ; Dipchand AI
    Circulation; 2007 Sep; 116(11 Suppl):I172-8. PubMed ID: 17846300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: an analysis of the United Network for Organ Sharing database.
    Rossano JW; Morales DL; Zafar F; Denfield SW; Kim JJ; Jefferies JL; Dreyer WJ
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):694-9, 699.e1-2. PubMed ID: 20537356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody.
    Hodges AM; Lyster H; McDermott A; Rice AJ; Smith JD; Rose ML; Banner NR
    Transplantation; 2012 Mar; 93(6):650-6. PubMed ID: 22245878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.
    Wright EJ; Fiser WP; Edens RE; Frazier EA; Morrow WR; Imamura M; Jaquiss RD
    J Heart Lung Transplant; 2007 Nov; 26(11):1163-9. PubMed ID: 18022083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.
    Everitt MD; Hammond ME; Snow GL; Stehlik J; Revelo MP; Miller DV; Kaza AK; Budge D; Alharethi R; Molina KM; Kfoury AG
    J Heart Lung Transplant; 2012 Jul; 31(7):686-93. PubMed ID: 22551931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
    George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
    J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in highly sensitized pediatric heart transplant patients using current management strategies.
    Asante-Korang A; Amankwah EK; Lopez-Cepero M; Ringewald J; Carapellucci J; Krasnopero D; Berg A; Quintessenza J; Jacobs JP
    J Heart Lung Transplant; 2015 Feb; 34(2):175-81. PubMed ID: 25447583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigen mismatching and HLA-specific antibodies in heart transplantation: review of a single center experience. The Manchester Wythenshawe Heart Transplant Team.
    Sheldon S; Dyer PA
    Transplant Proc; 1992 Dec; 24(6):2438. PubMed ID: 1465821
    [No Abstract]   [Full Text] [Related]  

  • 12. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
    Xydas S; Yang JK; Burke EM; Chen JM; Addonizio LJ; Mital SR; Itescu S; Hsu DT; Lamour JM
    J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantibodies in heart transplantation.
    Ho EK; Vlad G; Colovai AI; Vasilescu ER; Schwartz J; Sondermeijer H; Burke E; Marboe CC; Itescu S; Suciu-Foca N; Mancini D
    Hum Immunol; 2009 Oct; 70(10):825-9. PubMed ID: 19555730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the sensitized adult heart transplant candidate.
    Eckman PM; Hanna M; Taylor DO; Starling RC; Gonzalez-Stawinski GV
    Clin Transplant; 2010; 24(6):726-34. PubMed ID: 20482565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative analysis between survivors and nonsurvivors with antibody mediated cardiac allograft rejection.
    Gonzalez-Stawinski GV; Cook DJ; Chui J; Gupta S; Navia JL; Hoercher K; Taylor DO; Yamani MH; Starling RC; Smedira NG
    J Surg Res; 2007 Oct; 142(2):233-8. PubMed ID: 17727888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosensitization and outcomes in pediatric heart transplantation.
    Mahle WT; Tresler MA; Edens RE; Rusconi P; George JF; Naftel DC; Shaddy RE;
    J Heart Lung Transplant; 2011 Nov; 30(11):1221-7. PubMed ID: 21821435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex.
    Yang J; Schall C; Smith D; Kreuser L; Zamberlan M; King K; Gajarski R
    J Heart Lung Transplant; 2009 Feb; 28(2):123-9. PubMed ID: 19201336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.